Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Vincent Limburg"'
Autor:
Yevgen M Makogonenko, Dudley K. Strickland, Vincent Limburg, Natalya M. Ananyeva, Jose F. Ruiz, Diana V Kouiavskaia, Midori Shima, Alexey V. Khrenov, Evgueni L. Saenko, Alexander B. Meijer
Publikováno v:
Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 19(2)
Coagulation factor VIII (FVIII) is a ligand for two members of the low-density lipoprotein receptor family, low-density lipoprotein receptor-related protein (LRP) and low-density lipoprotein receptor, which cooperate in regulating clearance of FVIII
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edb6276522152750f57c50fa08622804
https://pubmed.ncbi.nlm.nih.gov/18277139
https://pubmed.ncbi.nlm.nih.gov/18277139
Autor:
Koen Mertens, Carmen van der Zwaan, Sigrid D. Roosendaal, Kees W. Rodenburg, Alexander B. Meijer, Vincent Limburg
Publikováno v:
Blood. 110:1766-1766
The platelet α-granules contain a unique pool of partially activated factor V, which has been suggested to originate form megakaryocyte endocytosis of factor V (FV) from plasma. The presence of activated FV (FVa) in plasma itself should be tightly c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::287fa2769bfd98a96e2d1ca7f7e0b56e
https://doi.org/10.1182/blood.v110.11.1766.1766
https://doi.org/10.1182/blood.v110.11.1766.1766
Autor:
Sigrid D. Roosendaal, Maartje van den Biggelaar, Alexander B. Meijer, Carmen van der Zwaan, Koen Mertens, Vincent Limburg, Kees W. Rodenburg, Bas de Laat
Publikováno v:
Blood. 110:1767-1767
Von Willebrand Factor (VWF) protects Factor VIII (FVIII) from rapid clearance of the cofactor from the circulations. This notion may agree with the observation that VWF blocks FVIII binding to LDL receptor (LDLR) and LDL receptor-related protein (LRP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdba7b2ade215835c8f739b4d44b67ec
https://doi.org/10.1182/blood.v110.11.1767.1767
https://doi.org/10.1182/blood.v110.11.1767.1767
Autor:
Koen Mertens, David Gestel, Alexander B. Meijer, Ed E. Moret, Vincent Limburg, Gunny van Stempvoort
Publikováno v:
Blood. 110:1762-1762
The formation of inhibitors against Factor VIII (FVIII) is one of the major adverse effects of FVIII substitution therapy in hemophilia A patients. Previously we have cloned a panel of antibodies from a phage display library from the VH gene repertoi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcd3696873e597bb07e2d762a7db9be4
https://doi.org/10.1182/blood.v110.11.1762.1762
https://doi.org/10.1182/blood.v110.11.1762.1762